Candel Therapeutics, Inc.

CADL · Healthcare · Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients

Candel Therapeutics, Inc. (CADL), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 2 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 11 and filed Sep 11. The most active filer was Paul Peter Tak with 5 filings.

Add to watchlist

Filings, ttm

1 buy · 2 sells · 1 late

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$6.4M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 11

Filed Sep 11

ADViAverage daily dollar volume

$19.8M

market data

Share price · 12M

$10.85 (+107.5%)

Adjusted for splits and dividends.

Volume by month

Buys $10.5M Sells $6.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Paul Peter Tak Chief Executive Officer 5 filings FB

Francesca Barone Chief Scientific Officer 4 filings ST

Seshu Tyagarajan Chief Technology Officer 4 filings PM

Paul B Manning Director 2 filings EC

Estuardo Aguilar-Cordova 10% owner 1 filing WN

William Garrett Nichols Chief Medical Officer 1 filing

Recent filings

Paul Peter TakSALE Chief Executive Officer $3.2M
280,245 sh across 2 lots
Exec Sep 10
Filed Sep 11 · 6:12 PM ET Francesca BaroneSALE Chief Scientific Officer $236K
23,447 sh × $10.06
Exec Jun 29
Filed Jul 1 · 4:22 PM ET Paul B ManningPURCHASE Director $3.0M
550,458 sh × $5.45
Exec Feb 23
Filed Feb 26 · 7:38 PM ET † Seshu TyagarajanSALE Chief Technology Officer $276K
31,278 sh × $8.82
Exec Mar 17 2025
Filed Mar 20 2025 · 5:30 PM ET † Paul Peter TakSALE Chief Executive Officer $226K
25,772 sh × $8.77
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET Francesca BaroneSALE Chief Scientific Officer $282K
32,146 sh × $8.76
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET William Garrett NicholsSALE Chief Medical Officer $397K
45,316 sh × $8.76
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET Seshu TyagarajanSALE Chief Technology Officer $276K
31,278 sh × $8.82
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET Paul Peter TakSALE Chief Executive Officer $157K
21,704 sh × $7.23
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET Seshu TyagarajanSALE Chief Technology Officer $104K
14,322 sh × $7.23
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET Seshu TyagarajanSALE Chief Technology Officer $120K
14,545 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET Paul Peter TakSALE Chief Executive Officer $174K
21,172 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET Francesca BaroneSALE Chief Scientific Officer $112K
13,673 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET Paul B ManningPURCHASE Director $7.5M
1,250,000 sh across 2 lots
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET Francesca BaroneSALE Chief Scientific Officer $101K
22,081 sh × $4.56
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET Paul Peter TakSALE Chief Executive Officer $223K
48,847 sh × $4.56
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET Estuardo Aguilar-CordovaSALE 10% owner $187K
26,988 sh × $6.92
Exec Oct 2 2024
Filed Oct 3 2024 · 5:30 PM ET